Fasching, PA; Abad, MF; Garcia-Saenz, JA; Schneeweiss, A; Guarneri, V; Colleoni, M; Petru, E; Costigan, TM; Caldwell, CW; Barriga, S; Hurvitz, S; Slamon, D.
Biological and clinical effects of abemaciclib in a phase 2 neoadjuvant study for postmenopausal patients with HR+/HER2-breast cancer.
ONCOL RES TREAT. 2017; 40: 225-226.-SABCS; 8.12.2017; San Antonio, USA.
[Oral Communication]
Web of Science